Oak Brook, IL – The Society for Laboratory Automation and Screening (SLAS) and Elsevier will host a free webinar to connect researchers and scientists across Asia with opportunities to publish, collaborate and engage with an international scientific community through the SLAS journals. The webinar takes place Wednesday, September 23, 2026, 5:30 AM CDT / 4:00 PM New Delhi / 6:30 PM Beijing.
Researchers throughout Asia play an important role in the SLAS journal community, with Asia representing the leading region for submissions across both SLAS Discovery and SLAS Technology and particularly strong engagement from mainland China.
Register at slas.org/journals-webinar
At the center of the webinar are SLAS’s two peer-reviewed, open access journals:
SLAS Discovery publishes innovative research advancing drug discovery and life sciences R&D, focusing on enabling technologies, approaches and applications that improve the discovery and development of new therapeutics.
SLAS Technology publishes research on innovative technologies, methods and applications that advance laboratory science and automation, including instrumentation, diagnostics, microfluidics, artificial intelligence and other emerging technologies.
Asian researchers are strongly represented among SLAS authors, with mainland China and India among the journals’ top contributing countries.
Whether you are considering submitting your research, want to learn more about the journals and their editorial priorities or are interested in connecting with the broader SLAS scientific community, this session will introduce opportunities to publish, contribute and get involved.
During this webinar, you will:
The webinar will be hosted live on Microsoft Teams, with access also available through WeChat and Weibo.
***
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2025 Impact Factor 3.3. Editor-in-Chief Robert M. Campbell, PhD, Grove Biopharma, Inc., Chicago, IL (USA).
SLAS Technology: Translating Life Sciences Innovation, 2025 Impact Factor 3.7. Editor-in-Chief Edward Kai-Hua Chow, PhD, KYAN Technologies, Los Angeles, CA (USA).
###